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Abstract
Background: In 2004, a review of pilot studies published in seven major medical journals during 2000-01 
recommended that the statistical analysis of such studies should be either mainly descriptive or focus on sample size 
estimation, while results from hypothesis testing must be interpreted with caution. We revisited these journals to see 
whether the subsequent recommendations have changed the practice of reporting pilot studies. We also conducted a 
survey to identify the methodological components in registered research studies which are described as 'pilot' or 
'feasibility' studies. We extended this survey to grant-awarding bodies and editors of medical journals to discover their 
policies regarding the function and reporting of pilot studies.
Methods: Papers from 2007-08 in seven medical journals were screened to retrieve published pilot studies. Reports of 
registered and completed studies on the UK Clinical Research Network (UKCRN) Portfolio database were retrieved and 
scrutinized. Guidance on the conduct and reporting of pilot studies was retrieved from the websites of three grant 
giving bodies and seven journal editors were canvassed.
Results: 54 pilot or feasibility studies published in 2007-8 were found, of which 26 (48%) were pilot studies of 
interventions and the remainder feasibility studies. The majority incorporated hypothesis-testing (81%), a control arm 
(69%) and a randomization procedure (62%). Most (81%) pointed towards the need for further research. Only 8 out of 
90 pilot studies identified by the earlier review led to subsequent main studies. Twelve studies which were 
interventional pilot/feasibility studies and which included testing of some component of the research process were 
identified through the UKCRN Portfolio database. There was no clear distinction in use of the terms 'pilot' and 
'feasibility'. Five journal editors replied to our entreaty. In general they were loathe to publish studies described as 'pilot'.
Conclusion: Pilot studies are still poorly reported, with inappropriate emphasis on hypothesis-testing. Authors should 
be aware of the different requirements of pilot studies, feasibility studies and main studies and report them 
appropriately. Authors should be explicit as to the purpose of a pilot study. The definitions of feasibility and pilot 
studies vary and we make proposals here to clarify terminology.
Background
A brief definition is that a pilot study is a 'small study for
helping to design a further confirmatory study'[1]. A very
useful discussion of exactly what is a pilot study has been
given by Thabane et al. [2] Such kinds of study may have
various purposes such as testing study procedures, valid-
ity of tools, estimation of the recruitment rate, and esti-
mation of parameters such as the variance of the outcome
variable to calculate sample size etc. In pharmacological
t r i a l s  t h e y  m a y  b e  r e f e r r e d  t o  a s  ' p r o o f  o f  c o n c e p t '  o r
Phase I or Phase II studies. It has become apparent to us
when reviewing research proposals that small studies
with all the trappings of a major study, such as random-
ization and hypothesis testing may be labeled a 'pilot'
because they do not have the power to test clinically
meaningful hypotheses. The authors of such studies per-
haps hope that reviewers will regard a 'pilot' more favour-
ably than a small clinical trial. This lead us to ask when it
is legitimate to label a study as a 'pilot' or 'feasibility'
study, and what features should be included in these types
of studies.
Lancaster et al [3] conducted a review of seven major
medical journals in 2000-1 to produce evidence regarding
the components of pilot studies for randomized con-
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trolled trials. Their search included both 'pilot' and 'feasi-
bility' studies as keywords. They reported certain
recommendations: having clear objectives in a pilot study,
inappropriateness of mixing pilot data with main
research study, using mainly descriptive statistics
obtained and caution regarding the use of hypothesis
testing for conclusions. Arnold et al [1] recently reviewed
pilot studies particularly related to critical care medicine
by searching the literature from 1997 to 2007. They pro-
vided narrative descriptions of some pilot papers particu-
larly those describing critical care medicine procedures.
They pointed out that few pilot trials later evolved into
subsequent published major trials. They made useful dis-
tinctions between: pilot work which is any background
research to inform a future study, a pilot study which has
specific hypotheses, objectives and methodology and a
pilot trial which is a stand-alone pilot study and includes
a randomization procedure. They excluded feasibility
studies from their consideration.
Thabane et al [2] gave a checklist of what they think
should be included in a pilot study. They included 'feasi-
bility' or 'vanguard' studies but did not distinguish them
from pilot studies. They provided a good discussion on
how to interpret a pilot study. They stress that not only
the outcome or surrogate outcome for the subsequent
main study should be described but also that a pilot study
should have feasibility outcomes which should be clearly
defined and described. Their article was opinion based
and not supported by a review of current practice.
The objective of this paper is to provide writers and
r e v i e w e r s  o f  r e s e a r c h  p r o p o s a l s  w i t h  e v i d e n c e  f r o m  a
variety of sources for which components they should
expect, and which are unnecessary or unhelpful, in a
study which is labeled as a pilot or feasibility study. To do
this we repeated Lancaster et al's [3] review for current
papers see if there has been any change in how pilot stud-
ies were reported since their study. As many pilot studies
are never published we also identified pilot studies which
were registered with the UK Clinical Research Network
(UKCRN) Portfolio Database. This aims to be a "complete
picture of the clinical research which is currently taking
place across the UK". All studies included have to have
been peer reviewed through a formal independent pro-
cess. We examined the websites of some grant giving
bodies to find their definition of a pilot study and their
funding policy toward them. Finally we contacted editors
o f  l e a d i n g  m e d i c a l  j o u r n a l s  t o  d i s c o v e r  t h e i r  p o l i cy  o f
accepting studies described as 'pilot' or 'feasibility'.
Methods
Literature survey
MEDLINE, Web of Science and university library data
bases were searched for the years 2007-8 using the same
key words "Pilot" or "Feasibility" as used by Lancaster et
al. [3]. We reviewed the same four general medicine jour-
nals: the British Medical Journal (BMJ), Lancet, the New
England Journal of Medicine (NEJM) and the Journal of
American Medical Association (JAMA) and the same
three specialist journals: British Journal of Surgery (BJS),
British Journal of Cancer (BJC), British Journal of Obstet-
rics and Gynecology (BJOG). We excluded review papers.
The full text of the relevant papers was obtained. GL
reviewed 20 papers and classified them into groups as
described in her original paper [3]. Subsequently MA, in
discussion with MC, designed a data extraction form to
classify the papers. We changed one category from GL's
original paper. We separated the category 'Phase I/II tri-
als' from the 'Piloting new treatment, technique, combi-
nation of treatments' category. We then classified the
remaining paper into the categories described in Table 1.
The total number of research papers by journal was
obtained by searching journal article with abstracts
(excluding reviews) using Pubmed. We searched citations
to see whether the pilot studies identified by Lancaster et
al [3] eventually led to main trials.
Portfolio database review
The (UKCRN) Portfolio Database was searched for the
terms 'feasibility' or 'pilot' in the title or research sum-
mary. Duplicate cases and studies classified as 'observa-
tional' were omitted. From the remaining studies those
classified as 'closed' were selected to exclude studies
which may not have started or progressed. Data were
extracted directly from the research summary of the
database or where that was insufficient the principle
investigator was contacted for related publications or
study protocols.
Editor and funding agency survey
We wrote to the seven medical journal editors of the
same journals used by Lancaster et al. [3], (BMJ, Lancet,
NEJM, JAMA. BJS, BJC and BJOG) and looked at the pol-
icies of three funding agencies (British Medical Research
Council, Research for Patient Benefit and NETSCC
(National Institute for Health Research Trials and Studies
C o o r d i n a t i n g  C e n t r e ) .  W e  w i s h e d  t o  e x p l o r e  w h e t h e r
there was any specified policy of the journal for publish-
ing pilot trials and how the editors defined a pilot study.
We also wished to see if there was funding for pilot stud-
ies.
Results
Literature survey
Initially 77 papers were found in the target journals for
2007-8 but 23 were review papers or commentaries or
indirectly referred to the word "pilot" or "feasibility" and
were not actually pilot studies leaving a total of 54 papers.
Table 1 shows the results by journal and by type of studyArain et al. BMC Medical Research Methodology 2010, 10:67
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Table 1: Literature search using key words "Pilot" OR "Feasibility"
Journal Name
BMJ Lancet NEJM JAMA BJS BJC BJOG Total
2007-8
Original articles 6 5 5 1 10 16 10 541 (1.6%)
Pilot or feasibility study in preparation for a trial 0 3 3 0 2 1 3 12
Piloting new technique, combination of treatments 1 0 0 0 4 2 6 13
Phase I, II trials 0 1 1 0 0 7 0 9
Piloting screening program 2 0 0 1 1 1 0 5
Piloting guidelines, educational package, patient care strategy 3 1 0 0 2 3 1 10
Laboratory testing of activity of compounds 0 0 1 0 1 2 0 4
Total research papers 292 379 444 383 338 1084 398 3318
2000-12
Original articles 11 17 3 7 9 33 10 90 (2.0%)
Total research papers 372 1115 434 619 396 1132 381 4449
1 excluded Review = 8, Commentaries = 4, News = 3, Indirectly referring to previous pilot = 9
2 from Lancaster et al [1]
and also shows the numbers reported by Lancaster et al.
[3] for 2000-01 in the same medical journals. There was a
decrease in the proportion of pilot studies published over
the period of time, however the difference was not statis-
tically significant (2.0% vs 1.6%; X2 = 1.6, P = 0.2). It is
noticeable that the Phase I or Phase II studies are largely
confined to the cancer journals.
L a n c a s t e r  e t  a l  [ 3 ]  f o u n d  t h a t  5 0 %  o f  p i l o t  s t u d i e s
reported the intention of further work yet we identified
only 8 (8.8%) which were followed up by a major study. Of
these 2 (25%) were published in the same journal as the
pilot.
Twenty-six of the studies found in 2007-8 were
described as pilot or feasibility studies for randomized
clinical trials (RCTs) including Phase II studies. Table 2
gives the numbers of studies which describe specific
components of RCTs. Sample size calculations were per-
formed and reported in 9 (36%) of the studies. Hypothesis
testing and performing inferential statistics to report sig-
nificant results was observed in 21 (81%) of pilot studies.
The processes of blinding was observed in only 5 (20%)
although the randomization procedure was applied or
tested in 16 (62%) studies. Similarly a control group was
assigned in most of the studies (n = 18; 69%). As many as
21 (81%) of pilot studies suggested the need for further
investigation of the tested drug or procedure and did not
report conclusive results on the basis of their pilot data.
The median number of participants was 76, inter-quartile
range (42, 216).
Of the 54 studies in 2007-8, a total of 20 were described
as 'pilot' and 34 were described as 'feasibility' studies.
Table 3 contrasts those which were identified by the key-
word 'pilot' with those identified by 'feasibility'. Those
using 'pilot' were more likely to have a pre-study sample
size estimate, to use randomization and to use a controlArain et al. BMC Medical Research Methodology 2010, 10:67
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group. In the 'pilot' group 16(80%) suggested further
study, in contrast to 15 (44%) in the 'feasibility' group.
Portfolio database review
A total of 34 studies were identified using the term 'feasi-
bility' or 'pilot' in the title or research summary which
were prospective interventional studies and were closed,
i.e. not currently running and available for analysis. Only
12 studies were interventional pilot/feasibility studies
which included testing of some component of the
research process. Of these 5 were referred to as 'feasibil-
ity', 6 as 'pilot' and 1 as both 'feasibility' and 'pilot' (Table
4).
The methodological components tested within these
studies were: estimation of sample size; number of sub-
jects eligible; resources (e.g. cost), time scale; population-
related (e.g. exclusion criteria), randomisation process/
acceptability; data collection systems/forms; outcome
measures; follow-up (response rates, adherence); overall
design; whole trial feasibility. In addition to one or more
of these, some studies also looked at clinical outcomes
including: feasibility/acceptability of intervention; dose,
efficacy and safety of intervention.
The results are shown in Table 4. Pilot studies alone
included estimation of sample size for a future bigger
study and tested a greater number of components in each
study. The majority of the pilots and the feasibility studies
ran the whole study 'in miniature' as it would be in the full
study, with or without randomization.
As an example of a pilot study consider 'CHOICES: A
pilot patient preference randomised controlled trial of
admission to a Women's Crisis House compared with psy-
chiatric hospital admissions' http://www.iop.kcl.ac.uk/
projects/default.aspx?id=10290. This study looked at
multiple components of a potential bigger study. It aimed
to determine the proportion of women unwilling to be
randomised, the feasibility of a patient preference RCT
design, the outcome and cost measures to determine
which outcome measures to use, the recruitment and
drop out rates; and to estimate the levels of outcome vari-
ability to calculate sample sizes for the main study. It also
intended to develop a user focused and designed instru-
ment which is the outcome from the study. The sample
size was 70.
Editor and funding agency survey
The editors of five (out of seven) medical journals
responded to our request for information regarding pub-
lishing policy for pilot studies. Four of the journals did
not have a specified policy about publishing pilot studies
and mostly reported that pilot trials cannot be published
if the standard is lower than a full clinical trial require-
ment. The Lancet has started creating space for prelimi-
nary phase I trials and set a different standard for
preliminary studies. Most of the other journals do not
encourage the publication of pilot studies because they
consider them less rigorous than main studies. Neverthe-
less some editors accepted pilot studies for publication by
compromising only on the requirement for a pre-study
sample size calculation. All other methodological issued
were considered as important as for the full trials, such as
trial registration, randomization, hypothesis testing, sta-
tistical analysis and reporting according to the CON-
SORT guidelines.
All three funding bodies made a point to note that pilot
and feasibility studies would be considered for funding.
Thabane et al [2] provided a list of websites which define
pilot or feasibility studies. We considered the NETSCC
definition to be most helpful and to most closely mirror
what investigators are doing and it is given below.
NETSCC definition of pilot and feasibility studies
http://www.netscc.ac.uk/glossary/
Feasibility Studies
Feasibility Studies are pieces of research done before a
main study. They are used to estimate important parame-
ters that are needed to design the main study. For
instance:
• standard deviation of the outcome measure, which 
is needed in some cases to estimate sample size,
• willingness of participants to be randomised,
• willingness of clinicians to recruit participants,
• number of eligible patients,
• characteristics of the proposed outcome measure 
and in some cases feasibility studies might involve 
designing a suitable outcome measure,
• follow-up rates, response rates to questionnaires, 
adherence/compliance rates, ICCs in cluster trials, 
etc.
Feasibility studies for randomised controlled trials may
not themselves be randomised. Crucially, feasibility stud-
Table 2: Literature survey: Frequency of methodological 
components appearing in pilot or feasibility studies of 
interventions (n = 261) in 2007-8
n (%)
Sample size calculation 9 (35%)
Hypothesis testing 21 (81%)
Randomization 16 (62%)
Blinding 5 (19%)
Control group 18 (69%)
Further study suggested 21 (81%)
Median number of 
participants (IQR)
76 [8, 1299]
1Pilot studies = 14 Feasibility studies = 12Arain et al. BMC Medical Research Methodology 2010, 10:67
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ies do not evaluate the outcome of interest; that is left to
the main study.
If a feasibility study is a small randomised controlled
trial, it need not have a primary outcome and the usual
sort of power calculation is not normally undertaken.
Instead the sample size should be adequate to estimate
the critical parameters (e.g. recruitment rate) to the nec-
essary degree of precision.
Pilot studies
A Pilot Study is a version of the main study that is run in
miniature to test whether the components of the main
study can all work together. It is focused on the processes
of the main study, for example to ensure recruitment,
randomisation, treatment, and follow-up assessments all
run smoothly. It will therefore resemble the main study in
many respects. In some cases this will be the first phase of
the substantive study and data from the pilot phase may
contribute to the final analysis; this can be referred to as
an internal pilot. Alternatively at the end of the pilot
study the data may be analysed and set aside, a so-called
external pilot.
Discussion
In our repeat of Lancaster et al's study [3] we found that
the reporting of pilot studies was still poor. It is generally
accepted that small, underpowered clinical trials are
unethical [4]. Thus it is not an excuse to label such a study
as a pilot and hope to make it ethical. We have shown that
pilot studies have different objectives to RCTs and these
should be clearly described. Participants in such studies
should be informed that they are in a pilot study and that
there may not be a further larger study.
It is helpful to make a more formal distinction between
a 'pilot' and a 'feasibility' study. We found that studies
labeled 'feasibility' were conducted with more flexible
methodology compared to those labeled 'pilot'. For exam-
ple the term 'feasibility' has been used for large scale stud-
ies such as a screening programme applied at a
population level to determine the initial feasibility of the
programme. On the other hand 'pilot' studies were
reported with more rigorous methodological compo-
nents like sample size estimation, randomization and
control group selection than studies labeled 'feasibility'.
We found the NETSCC definition to be the most helpful
since it distinguishes between these types of study.
In addition it was observed that most of the pilot stud-
ies report their results as inconclusive, with the intention
of conducting a further, larger study. In contrast, several
of the feasibility studies did not admit such an intention.
On the basis of their intention one would have expected
Table 3: Literature survey: Comparison of studies (n = 54) using the key words feasibility or pilot
Study components Pilot n = 20 Feasibility n = 34 Chi-squared1 P-value
Sample size 7 (35%) 3 (8%) 5.7 0.028
Hypothesis testing 14 (70%) 25 (74%) 0.78 0.51
Randomization 11 (55%) 8 (24%) 5.5 0.037
Blinding 3 (15%) 3 (9%) 0.48 0.39
Control group 13 (65%) 11 (32%) 5.4 0.020
Further study suggested 16 (80%) 15 (44%) 6.6 0.012
Number of participants Median (IQR) 
[Range]
62.5 (31, 189) [8, 187777] 125.5 (36, 1005) [5, 12774614] -1.04* 0.29
1 1 degree of freedom
* z-statistic (Mann-Whitney test)
Table 4: Portfolio database survey: comparison of 
components in studies termed pilot or feasibility
Pilot n = 6 Feasibility n = 5 Both n = 1
Methods related
Miniature RCT 4 3 0
Testing recruitment 4 1 0
Determining sample 
size/numbers available
30 1
Resources 1 0 0
Randomization 4 1 0
Outcome measures 2 4 2
Data collection 1 0 0
Follow up/dropout 2 0 0
Intervention related
Clinical outcomes 3 1 1
Dose/efficacy/safety 0 1 0
Acceptability 2 0 1
Feasibility 3 0 1Arain et al. BMC Medical Research Methodology 2010, 10:67
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about 45 of the studies identified by Lancaster et al in
2000/1 to have been followed by a bigger study whereas
we only found 8. This would reflect the opinion of most
of the journal editors and experts who responded to our
survey, who felt that pilot studies rarely act as a precursor
for a bigger study. The main reason given was that if the
pilot shows significant results then researchers may not
find it necessary to conduct the main trial. In addition if
the results are unfavorable or the authors find an unfeasi-
ble procedure, the main study is less likely to be consid-
ered useful. Our limited review of funding bodies was
encouraging. Certainly when reviewing grant applica-
tions, we have found it helpful to have the results of a
pilot study included in the bid. We think that authors of
pilots studies should be explicit as to their purpose, e.g. to
test a new procedure in preparation for a clinical trial. We
also think that authors of proposals for pilot studies
should be more explicit as to the criteria which lead to
further studies being abandoned, and that this should be
an important part of the proposal.
In the Portfolio Database review, only pilot studies cited
an intention to estimate sample size calculations for
future studies and the majority of pilot studies were full
studies run with smaller sample sizes to test out a number
of methodological components and clinical outcomes
simultaneously. In comparison the feasibility studies
tended to focus on fewer methodological components
within individual studies. For example, the 6 pilot studies
reported the intention to evaluate a total of 17 method-
ological components whereas in the 5 feasibility studies a
total of only 6 methodological components were specifi-
cally identified as being under investigation (Table 4).
However, both pilot and feasibility studies included trials
run as complete studies, including randomization, but
with sample sizes smaller than would be intended in the
full study and the distinction between the two terms was
not clear-cut.
Another reason for conducting a pilot study is to pro-
vide information to enable a sample size calculation in a
subsequent main study. However since pilot studies tend
to be small, the results should be interpreted with caution
[5]. Only a small proportion of published pilot studies
reported pre-study sample size calculations. Most journal
editors reported that a sample size calculation is not a
mandatory criterion for publishing pilot studies and sug-
gested that it should not be done.
Some authors suggest that analysis of pilot studies
should mainly be descriptive,[3,6] as hypothesis testing
requires a powered sample size which is usually not avail-
able in pilot studies. In addition, inferential statistics and
testing hypothesis for effectiveness require a control arm
which may not be present in all pilot studies. However
most of the pilot interventional studies in this review
contained a control group and the authors performed and
reported hypothesis testing for one or more variables.
Some tested the effectiveness of an intervention and oth-
ers just performed statistical testing to discover any
important associations in the study variables. Observed
practice is not necessarily good practice and we concur
with Thabane et al [2] that any testing of an intervention
needs to be reported cautiously.
The views of the journal editors, albeit from a small
sample, were not particularly encouraging and reflected
the experience of Lancaster et al [3]. Pilot studies, by their
nature, will not produce 'significant' (i.e P < 0.05) results.
We believe that publishing the results of well conducted
pilot or feasibility studies is important for research, irre-
spective of outcome.. There is an increasing awareness
that publishing only 'significant' results can lead to con-
siderably error [7]. The journals we considered were all
established, paper journals and perhaps the newer elec-
tronic journals will be more willing to consider the publi-
cation of the results from these types of studies.
We may expect that trials will increasingly be used to
evaluate 'complex interventions'[8,9]. The MRC guide-
lines [8] explicitly suggest that preliminary studies,
including pilots, be used prior to any major trial which
seeks to evaluate a package of interventions (such as an
educational course), rather than a single intervention
(such as a drug). Thus it is likely that reviewers will be
increasingly asked to pronounce on these and will require
guidance as to how to review them.
Conclusions
We conclude that pilot studies are still poorly reported,
with inappropriate emphasis on hypothesis-testing. We
believe authors should be aware of the different require-
ments of pilot studies and feasibility studies and report
them appropriately. We found that in practice the defini-
tions of feasibility and pilot studies are not distinct and
vary between health research funding bodies and we sug-
gest use of the NETSCC definition to clarify terminology.
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